SPOTLIGHT -
Breast Cancer Treatment: Sequencing With Antibody-Drug Conjugates
Clinical pearls regarding ways to integrate antibody-drug conjugates into treatment algorithms when managing patients with breast cancer.
Read More
Sacituzumab Govitecan Safety Profile in TNBC
Strategies that can be used to mitigate and manage adverse events associated with sacituzumab govitecan therapy for triple-negative breast cancer.
Managing Patients With MBC on T-DXd Therapy
Strategies used to help monitor and manage T-DXd treatment-related adverse events.
T-DXd for HER2+ Metastatic Breast Cancer
Recommendations for starting a patient with HER2+ metastatic breast cancer on T-DXd after prior T-DM1 therapy.
Long-Term HRQOL Remains Unimpaired With HIPEC Plus Cytoreductive Surgery in Newly Diagnosed Ovarian Cancer
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
